2017 annual financial data
Aurinia Pharmaceuticals 2017 Revenue growth
Direct answer
Revenue growth was 142.77%.
Operating income was -47,063,000 USD and net income was -70,792,000 USD.
Operating cash flow was -41,169,000 USD.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 420,000 USD
- Operating income
- -47,063,000 USD
- Net income
- -70,792,000 USD
- Operating cash flow
- -41,169,000 USD